J&J partners with pair of Canadian companies

The Janssen Inc. unit of Johnson & Johnson (NYSE:JNJ) started separate collaborations with gene therapy company enGene Inc. (Montreal, Quebec) to treat inflammatory bowel disease (IBS) and oncology start-up Novera

Read the full 302 word article

How to gain access

Continue reading with a
two-week free trial.